A comparative study of Lrrk2 function in primary neuronal cultures.

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Mutations in leucine-rich repeat kinase-2 (LRRK2) are a primary genetic cause of Parkinson's disease.
• Developing cellular assays for LRRK2 mutant function is crucial for targeted molecular therapeutics.

Purpose of the Study:

• To investigate the impact of wild-type, mutant, and absent leucine-rich repeat kinase-2 (LRRK2) on dendritic neuronal arborization.
• To establish a cellular model for studying LRRK2 gain-of-function mutations relevant to Parkinson's disease.

Main Methods:

• Quantified dendritic neuronal arborization (neurite length, branching, process number) in primary hippocampal and midbrain cultures.
• Utilized five lines of recombinant LRRK2 mice: human BAC wild-type and mutant (Y1699C, G2019S) overexpressors, murine LRRK2 knock-out, and G2019S knock-in models.

Main Results:

• LRRK2 over-expression in BAC wild-type mice did not affect neuronal arborization compared to controls.
• BAC mutant LRRK2 overexpressors showed significantly reduced neuritic outgrowth and branching, indicating a toxic gain-of-function.
• Neuronal arborization was more extensive in LRRK2 knock-out mice, suggesting a role in regulating neurite growth.
• The LRRK2 G2019S knock-in model, considered more physiologically relevant, did not display impaired neuritic arborization.

Conclusions:

• Impaired neuritic arborization is a specific consequence of LRRK2 over-expression, not LRRK2 loss or wild-type expression.
• The described phenotype and assay system can facilitate the development of therapeutics targeting the toxic gain-of-function of mutant LRRK2 in Parkinson's disease.